Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender differences in a causal model of risk factors underlying early alcohol sipping.

Child and adolescent psychiatry and mental health·2026
Same author

ATP bioenergetics and fatigue in young adults with and without major depression.

Translational psychiatry·2026
Same author

Dynamic Functional Connectivity, Major Depression, and Suicidal Ideation in Children.

Human brain mapping·2026
Same author

Examining Causal Pathways to Suicidal Ideation and Nonsuicidal Self-Injury in the Adolescent Brain Cognitive Development Study.

Suicide & life-threatening behavior·2025
Same author

Mortality cues in a high-resource context: Minority stress, suicide exposure, and pubertal development.

The Behavioral and brain sciences·2025
Same author

What parents tell us about the complex reality of lethal means restriction.

BJPsych open·2025

Related Experiment Video

Updated: Jun 23, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Pediatric depression: issues and treatment recommendations.

Kathryn Cullen1, Bonnie Klimes-Dougan, Sanjiv Kumra

  • 1Division of Child and Adolescent Psychiatry, University of Minnesota, USA.

Minnesota Medicine
|April 30, 2009
PubMed
Summary

Major depressive disorder in adolescents requires early intervention. This review examines antidepressant risks versus untreated illness, highlighting combination therapy with fluoxetine and CBT for better outcomes.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Area of Science:

  • Child and Adolescent Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Major depressive disorder (MDD) in adolescents carries severe risks, including suicide.
  • Parental hesitancy towards antidepressant therapy stems from concerns about suicidal ideation and neurodevelopmental effects.
  • Untreated MDD poses significant risks to adolescent development.

Purpose of the Study:

  • To discuss current data on risks of antidepressant use in pediatric populations.
  • To compare these risks against the developmental impact of untreated adolescent depression.
  • To review evidence for combination treatments in non-responsive cases.

Main Methods:

  • Literature review of current data on antidepressant risks in children and adolescents.
  • Analysis of research on the effects of untreated MDD on adolescent development.
  • Examination of studies on combination therapy (e.g., fluoxetine and CBT).

Main Results:

  • Data on antidepressant risks in pediatric populations are discussed.
  • The risks associated with untreated adolescent depression are contrasted with potential medication side effects.
  • Recent research indicates combination treatment may be beneficial for non-responders.

Conclusions:

  • Balancing antidepressant risks with the dangers of untreated adolescent depression is critical.
  • Combination therapy, including fluoxetine and cognitive behavioral therapy, shows promise for treatment-resistant depression in adolescents.